Pegloticase: less risk of infusion reactions in `real world'

August 2013, Volume 1463, Issue 1, pp 3–3 | Cite as

Epidemiology clinical study

First Online: 03 August 2013

This is a preview of subscription content, to check access.

References

1.
Malamet R, et al. Real World Risk of Infusion Reactions with Pegloticase Treatment: Findings from Post-Approval Us Safety Data. 14th Annual Congress of the European League Against Rheumatism : abstr. SAT0355, 12 Jun 2013.Google Scholar
2.
Bahrt K, et al. Uric Acid Levels as a Biomarker of Efficacy and Safety in Patients Treated with Pegloticase: Lessons Learned from Us Clinical Experience. 14th Annual Congress of the European League Against Rheumatism : abstr. SAT0376, 12 Jun 2013.Google Scholar